ArticleOPEN ACCESS

Demonstration of additional benefit in adding lenalidomide to azacitidine in patients with higher-risk myelodysplastic syndromes

American Journal of Hematology
DOI: 10.1002/ajh.21891
46Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Sekeres, M. A., O’Keefe, C., List, A. F., Paulic, K., Afable, M., Englehaupt, R., & Maciejewski, J. P. (2011, January). Demonstration of additional benefit in adding lenalidomide to azacitidine in patients with higher-risk myelodysplastic syndromes. American Journal of Hematology. https://doi.org/10.1002/ajh.21891

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free